Abstract Multi-gene molecular testing panels demonstrated excellent performance characteristics for evaluation of indeterminate thyroid nodules and independently risk-stratified advanced tumor stage in the Chinese population. Findings support incorporating cost-conscious molecular diagnostics in an integrated pathway along with clinical, sonographic and cytologic features, while underscoring need for prospective validation in future studies.
Kartik Sehgal (Fri,) studied this question.